Sandra Calvin, Travere治疗公司首席会计, 卖掉一部分她的股票, 之后是其他执行官的销售。 Sandra Calvin, Travere Therapeutics' Chief Accounting Officer, sold a portion of her stock, following other executive sales.

Sandra Calvin,Travere治疗公司首席会计,最近出售了该公司的3 348股股票,将她的所有权减少了5%。 Sandra Calvin, the Chief Accounting Officer of Travere Therapeutics, recently sold 3,348 shares of the company's stock, reducing her ownership by 5%. 这是在包括首席执行官Eric M. Dube在内的其他几个高管销售之后发生的,他出售了他的相当大一部分股份。 This comes after several other sales by executives, including CEO Eric M. Dube, who sold a significant portion of his shares. 分析家给出了积极的展望,有些提高了价格目标。 Analysts have given positive outlooks, with some raising their price targets. 以稀有疾病为主的生物制药公司Travere治疗公司,其机构投资者也增加了其持有量。 Travere Therapeutics, a biopharmaceutical company focused on rare diseases, has seen institutional investors also increasing their holdings.